BG107605A - Тартаратни соли на тиазолидиндионово производно - Google Patents

Тартаратни соли на тиазолидиндионово производно Download PDF

Info

Publication number
BG107605A
BG107605A BG107605A BG10760503A BG107605A BG 107605 A BG107605 A BG 107605A BG 107605 A BG107605 A BG 107605A BG 10760503 A BG10760503 A BG 10760503A BG 107605 A BG107605 A BG 107605A
Authority
BG
Bulgaria
Prior art keywords
meso
tartrate
solvate
accordance
pyridyl
Prior art date
Application number
BG107605A
Other languages
Bulgarian (bg)
English (en)
Inventor
Andrew Craig
Tim HO
Michael Millan
Original Assignee
Smithkline Beecham P.L.C.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham P.L.C. filed Critical Smithkline Beecham P.L.C.
Publication of BG107605A publication Critical patent/BG107605A/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cosmetics (AREA)
BG107605A 2000-08-04 2003-02-28 Тартаратни соли на тиазолидиндионово производно BG107605A (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0019226.0A GB0019226D0 (en) 2000-08-04 2000-08-04 Novel pharmaceutical
PCT/GB2001/003514 WO2002012233A1 (en) 2000-08-04 2001-08-03 Tartrate salts of thiazolidinedione derivative

Publications (1)

Publication Number Publication Date
BG107605A true BG107605A (bg) 2003-09-30

Family

ID=9897028

Family Applications (1)

Application Number Title Priority Date Filing Date
BG107605A BG107605A (bg) 2000-08-04 2003-02-28 Тартаратни соли на тиазолидиндионово производно

Country Status (23)

Country Link
EP (1) EP1307448A1 (no)
JP (1) JP2004505971A (no)
KR (1) KR20030022356A (no)
CN (1) CN1458930A (no)
AP (1) AP2003002737A0 (no)
AU (1) AU2001276508A1 (no)
BG (1) BG107605A (no)
BR (1) BR0112984A (no)
CA (1) CA2417828A1 (no)
CZ (1) CZ2003314A3 (no)
EA (1) EA200300231A1 (no)
EC (1) ECSP034468A (no)
GB (1) GB0019226D0 (no)
HU (1) HUP0300770A2 (no)
IL (1) IL154277A0 (no)
MA (1) MA25830A1 (no)
MX (1) MXPA03001086A (no)
NO (1) NO20030508L (no)
OA (1) OA12355A (no)
PL (1) PL360702A1 (no)
SK (1) SK1452003A3 (no)
WO (1) WO2002012233A1 (no)
ZA (1) ZA200300962B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39384E1 (en) 1993-09-01 2006-11-07 Smithkline Beecham P.L.C. Substituted thiazolidinedione derivatives
FR2845602B1 (fr) * 2002-10-11 2005-07-08 Servier Lab Association entre un ligand des recepteurs actives par les proliferateurs de peroxisomes et un agent antioxydant et les compositions pharmaceutiques qui les contiennent
US7264813B2 (en) 2003-09-24 2007-09-04 Nikken Sohonsha Corporation Therapeutic uses of Dunaliella powder
CN102532122B (zh) * 2010-12-29 2015-12-02 开封制药(集团)有限公司 酒石酸罗格列酮的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds

Also Published As

Publication number Publication date
AU2001276508A1 (en) 2002-02-18
BR0112984A (pt) 2003-06-10
JP2004505971A (ja) 2004-02-26
OA12355A (en) 2004-03-19
EP1307448A1 (en) 2003-05-07
NO20030508L (no) 2003-03-20
KR20030022356A (ko) 2003-03-15
GB0019226D0 (en) 2000-09-27
SK1452003A3 (en) 2004-05-04
WO2002012233A1 (en) 2002-02-14
HUP0300770A2 (hu) 2003-11-28
PL360702A1 (en) 2004-09-20
MA25830A1 (fr) 2003-07-01
NO20030508D0 (no) 2003-01-31
CN1458930A (zh) 2003-11-26
CZ2003314A3 (cs) 2004-02-18
MXPA03001086A (es) 2003-05-27
ZA200300962B (en) 2003-10-29
IL154277A0 (en) 2003-09-17
ECSP034468A (es) 2003-03-31
EA200300231A1 (ru) 2003-06-26
AP2003002737A0 (en) 2003-03-31
CA2417828A1 (en) 2002-02-14

Similar Documents

Publication Publication Date Title
BG107606A (bg) Тартаратни соли на тиазолидиндионово производно
BG107605A (bg) Тартаратни соли на тиазолидиндионово производно
BG107607A (bg) Хидрохлоридна сол на 5-[4-[2-(n-метил-n-(2-пиридил)амино)етокси]бензил]тиазолидин-2,4-дион
BG107604A (bg) Тартаратна сол на тиазолидиндионово производно
KR100917953B1 (ko) 5-[4-[2-(ｎ-메틸-ｎ-(2-피리딜)아미노)에톡시]벤질]티아졸리딘-2,4-디온의 나트륨염
KR20030007918A (ko) 당뇨병 치료용 티아졸리딘디온 염
EP1305310B1 (en) Tartrate salts of thiazolidinedione derivative
US20040102485A1 (en) Tartrate salt of thiazolidinedione derivative
BG107356A (bg) 5-(4-(2-(n-метил-n-(2-пиридил)амино)етокси)бензил)тиазолидин-2,4-дион хидройодид като фармацевтиченсъстав
BG107678A (bg) Тиазолидиндионово производно и използването му като антидиабетично средство